Crucell - PDFSEARCH.IO - Document Search Engine

Crucell
Results: 25

#	Item
11	PROGRAM AT A GLANCE: TIME & PLACE Sunday, May 24, 2009 Danube Tent 14:[removed]:45 17:[removed]:00 Add to Reading List Source URL: istmsite.membershipsoftware.org Language: English - Date: 2013-07-02 12:53:45 Novartis Travel medicine Crucell Meningococcal disease Poster session Tent Poster Medicine Health Malaria
12	Johnson & Johnson and Bavarian Nordic Testimony before the U.S. Senate Committee on Appropriations Hearing on “U.S. Government Response: Fighting Ebola and Protecting America” November 12, 2014 Chairwoman Mikulski, R Add to Reading List Source URL: www.appropriations.senate.gov Language: English - Date: 2014-11-10 10:56:28 Microbiology Crucell Vaccine Ebola virus disease Biomedical Advanced Research and Development Authority MedImmune National Institutes of Health Medicine Biology Health
13	Microsoft Word - Document2 Add to Reading List Source URL: www.leidenbiosciencepark.nl Language: English - Date: 2010-07-15 04:44:55 Biology Clinical research Pharmacology Crucell Leiden Pharming
14	VACCINES (NON-FLU) (MMCAP) NON-MANDATORY FOR STATE AGENCIES AVAILABLE FOR POLITICAL SUBDIVISIONS This is a non-mandatory use contract offered to the State of Alaska (as a participating MMCAP state) for the purchase of no Add to Reading List Source URL: doa.alaska.gov Language: English - Date: 2014-10-30 18:10:18 Health Alaska Biology Crucell Influenza Vaccines Medicine Influenza vaccine
15	Presentation HepB vaccine in a single dose presentation HepB vaccine in a two dose Add to Reading List Source URL: www.unicef.org Language: English - Date: 2014-06-06 02:07:44 Pharmaceutical industry Sanofi Shantha Biotechnics Crucell
16	PROGRAM AT A GLANCE: TIME & PLACE Sunday, May 24, 2009 Danube Tent 14:[removed]:45 17:[removed]:00 Add to Reading List Source URL: www.istm.org Language: English - Date: 2013-07-02 12:53:45 Novartis Travel medicine Crucell Meningococcal disease Poster session Tent Poster Medicine Health Malaria
17	Merus Announces PER.C6® Licensing Agreement with Crucell for Production of Monoclonal Antibody Combinations For immediate release : June 10, 2004 Driebergen, The Netherlands - Dutch biotechnology company Crucell N.V. (E Add to Reading List Source URL: www.merus.nl Language: English - Date: 2009-12-18 05:59:50 Medicine Health Crucell Immunology Biologic Biopharmaceutical DSM Influenza vaccine Influenza Biology Biotechnology Pharmacology
18	Merus b.v. Licenses Oligoclonics™ Production Technology for Therapeutic Antibody Mixtures For immediate release: February 10, 2004 Driebergen, The Netherlands – Merus b.v. today announced that it has concluded an agr Add to Reading List Source URL: www.merus.nl Language: English - Date: 2009-12-18 05:59:50 Glycoproteins Biotechnology Crucell Monoclonal antibodies Antibody Immune system Biology Immunology
19	Microsoft Word[removed]Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional.docx Add to Reading List Source URL: www.crucell.com Language: English - Date: 2011-02-22 11:01:38 Equity securities Crucell Finance Economics Mergers and acquisitions Tender offer Takeover American depositary share Government procurement in the United States Corporate finance Financial economics Stock market
20	CONTACTS: Karen Manson, Media +[removed]mobile) Promising Results of Novel Combination Vaccine Preclinical Study Provides Strong Rationale for HIV Vaccine Clinical Trials Add to Reading List Source URL: www.crucell.com Language: English - Date: 2012-01-05 07:37:15 Vaccines Biology HIV vaccine HIV Nef Jaap Goudsmit Crucell Phillip T. and Susan M. Ragon Institute Influenza HIV/AIDS Medicine Health

UPDATE